Literature DB >> 21099684

Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease.

Jennifer L Wilkinson-Berka1, Antonia G Miller, Katrina J Binger.   

Abstract

PURPOSE OF REVIEW: The renin-angiotensin system (RAS) is a treatment target for diabetic retinopathy and possibly other ocular diseases. However, angiotensin II blockade, though beneficial in diabetic retinopathy, is not completely retinoprotective. There is speculation that this shortfall is due to incomplete suppression of other RAS components. This review discusses the possibility that prorenin, which initiates the RAS, and the (pro)renin receptor [(P)RR] are potential candidates. RECENT
FINDINGS: Despite prorenin being elevated in diabetic retinopathy, it remains unclear whether it exerts any functional effects in tissues, including the eye. Of interest are newly identified functions for the (P)RR based on its homology with an accessory protein of vacuolar ATPase, ATP6AP2. These include roles in the viability of the central nervous system, including the retina, via the Wnt signaling pathway. Additionally, (P)RR/ATP6AP2 is implicated in other vacuolar ATPase-related events, including the regulation of cellular pH in the kidney and cell survival. Yet to be determined is whether the effects of (P)RR/ATP6AP2 are relevant to retinal cell function in health and disease and require the participation of its ligand prorenin.
SUMMARY: New functions for the (P)RR highlight previously unrecognized roles for this receptor in cellular events that may have implications for both the developing and diseased retina.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21099684     DOI: 10.1097/MNH.0b013e328341328a

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

1.  Increased (pro)renin receptor expression in the subfornical organ of hypertensive humans.

Authors:  Silvana G Cooper; Darshan P Trivedi; Rieko Yamamoto; Caleb J Worker; Cheng-Yuan Feng; Jacob T Sorensen; Wei Yang; Zhenggang Xiong; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

Review 2.  New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Peptides       Date:  2011-06-14       Impact factor: 3.750

Review 3.  The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure.

Authors:  Quanbin Xu; Dane D Jensen; Hua Peng; Yumei Feng
Journal:  Pharmacol Ther       Date:  2016-04-23       Impact factor: 12.310

4.  MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells.

Authors:  Rashidul Haque; Elizabeth H Hur; Annie N Farrell; P Michael Iuvone; Jennifer C Howell
Journal:  Mol Vis       Date:  2015-03-07       Impact factor: 2.367

5.  Clinical application of exome sequencing in undiagnosed genetic conditions.

Authors:  Anna C Need; Vandana Shashi; Yuki Hitomi; Kelly Schoch; Kevin V Shianna; Marie T McDonald; Miriam H Meisler; David B Goldstein
Journal:  J Med Genet       Date:  2012-05-11       Impact factor: 6.318

6.  Direct pro-inflammatory effects of prorenin on microglia.

Authors:  Peng Shi; Justin L Grobe; Fiona A Desland; Guannan Zhou; Xiao Z Shen; Zhiying Shan; Meng Liu; Mohan K Raizada; Colin Sumners
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.